Detección molecular del papilomavirus humano de alto riesgo en el seguimiento de mujeres tratadas por lesión escamosa intraepitelial

Bobadilla, Maria Liz; Villagra, Veronica; Zorrilla, Maria E; Pratt, Pablo; Olmedo, Gladys; Roscher, Gladys; Franco, Franciso; Riveros, María C.
Mem. Inst. Invest. Cienc. Salud (Impr.) ; 14(1): 64-69, abr. 2016. tab
Artigo em Espanhol | LILACS, BDNPAR | ID: biblio-869071

Documentos relacionados

  1. Detección molecular del virus papiloma humano de alto riesgo oncogénico en muestras cervicales. laboratorio central de salud pública. primeros resultados
  2. Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States.
  3. Prevalencia de los Genotipos del Virus del Papiloma Humano en mujeres de 25 a 65 años
  4. Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test.
  5. Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
  6. Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3.
  7. Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
  8. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
  9. Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia.
  10. Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study.